172 related articles for article (PubMed ID: 1939654)
1. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells.
Marcus AJ; Safier LB; Hajjar KA; Ullman HL; Islam N; Broekman MJ; Eiroa AM
J Clin Invest; 1991 Nov; 88(5):1690-6. PubMed ID: 1939654
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism.
Broekman MJ; Eiroa AM; Marcus AJ
Blood; 1991 Aug; 78(4):1033-40. PubMed ID: 1868238
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions.
Marcus AJ; Safier LB; Broekman MJ; Islam N; Fliessbach JH; Hajjar KA; Kaminski WE; Jendraschak E; Silverstein RL; von Schacky C
Thromb Haemost; 1995 Jul; 74(1):213-7. PubMed ID: 8578460
[TBL] [Abstract][Full Text] [Related]
4. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
[TBL] [Abstract][Full Text] [Related]
5. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Alyonycheva TN; Safier LB; Hajjar KA; Posnett DN; Schoenborn MA; Schooley KA; Gayle RB; Maliszewski CR
J Clin Invest; 1997 Mar; 99(6):1351-60. PubMed ID: 9077545
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.
Marcus AJ; Weksler BB; Jaffe EA; Broekman MJ
J Clin Invest; 1980 Nov; 66(5):979-86. PubMed ID: 6776148
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C.
Durante W; Kroll MH; Vanhoutte PM; Schafer AI
Blood; 1992 Jan; 79(1):110-6. PubMed ID: 1309423
[TBL] [Abstract][Full Text] [Related]
8. Perindopril augments ecto-ATP diphosphohydrolase activity and enhances endothelial anti-platelet function in human umbilical vein endothelial cells.
Kishi Y; Ohta S; Kasuya N; Sakita SY; Ashikaga T; Isobe M
J Hypertens; 2003 Jul; 21(7):1347-53. PubMed ID: 12817183
[TBL] [Abstract][Full Text] [Related]
9. Contribution of ecto-5'-nucleotidase to the inhibition of platelet aggregation by human endothelial cells.
Kawashima Y; Nagasawa T; Ninomiya H
Blood; 2000 Sep; 96(6):2157-62. PubMed ID: 10979961
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
[TBL] [Abstract][Full Text] [Related]
11. Platelet aggregation induced by the endoperoxide analogue U46619 is inhibited by polymorphonuclear leukocyte ADPase activity.
Zatta A; Pandolfo L; Caparrotta L; Prosdocimi M; Dejana E; Del Maschio A
Arterioscler Thromb; 1993 May; 13(5):696-701. PubMed ID: 8485121
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
13. Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery.
Crutchley DJ; Ryan US; Ryan JW
J Clin Invest; 1980 Jul; 66(1):29-35. PubMed ID: 7400307
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
[TBL] [Abstract][Full Text] [Related]
15. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
18. Human endothelial cells maintain anti-aggregatory activity for platelets during apoptosis.
Xu W; Favaloro EJ; Medbury H; Zoellner H
Thromb Haemost; 2001 May; 85(5):915-23. PubMed ID: 11372688
[TBL] [Abstract][Full Text] [Related]
19. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model.
Buergler JM; Maliszewski CR; Broekman MJ; Kaluza GL; Schulz DG; Marcus AJ; Raizner AE; Kleiman NS; Ali NM
J Thromb Thrombolysis; 2005 Apr; 19(2):115-22. PubMed ID: 16052302
[TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Christie DJ; Kottke-Marchant K; Gorman RT
Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
